Bandingkan Harga & Kinerja Bahtera Bumi Raya Tbk. (PGJO) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Bahtera Bumi Raya Tbk. dan Organon Pharma Indonesia Tbk.: Bahtera Bumi Raya Tbk. diperdagangkan di Rp870 (kapitalisasi pasar 688,42 M, volume 24 jam 601,7 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Bahtera Bumi Raya Tbk. jauh lebih besar — sekitar 6,6× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| PGJO | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 688,42 M | 104,4 M |
Volume | 601,7 rb | — |
Lot | 6,02 rb | — |
Perputaran | 518,23 jt | — |
Harga Rata-rata | 861,27 | — |
Nilai Transaksi | 518,23 jt | — |
Harga Ekuilibrium Indikatif | 870 | — |
Volume Ekuilibrium Indikatif | 58 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Bahtera Bumi Raya Tbk.
PT Tourindo Guide Indonesia Tbk (the Company) was established based on Notarial Deed No. 22 dated February 20, 2017 of Argo Wahyu Jati, S.H., M.Kn., a public notary in Tangerang Selatan. The Company started its commercial operations in 2018.
Selengkapnya di halaman PGJO →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
